Brief: Botanix Pharmaceuticals Says NDA Resubmission Accepted
22/01/2024 01:15
Jan 22 (Reuters) - Botanix Pharmaceuticals Ltd BOT.AX :
* NDA RESUBMISSION ACCEPTED AND APPROVAL DATE CONFIRMED
* CO'S RESUBMISSION OF NDA FOR SOFDRA ACCEPTED BY FDA AS A
COMPLETE RESPONSE
Source text for Eikon: ID:nASXbSlb4s
Further company coverage: BOT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Botanix Pharmaceuticals
See all newsBrief: Botanix Pharmaceuticals Receives Notice Of Allowance For Additional US Patent Covering Sofdra Drug Substance
Brief: Botanix Pharmaceuticals Appoints Paul Seaback As Chief Operating Officer
Brief: Botanix Pharmaceuticals Reaches Term Sheet Agreement With Second API Supplier
Botanix Pharmaceuticals jumps on supply agreement with PPL Pharma Solutions
Brief: Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 Million